CBPO [China Biologic Products] 8-K: FOR RELEASE November 3, 2015 China Biologic Reports

[FOR RELEASE November 3, 2015 China Biologic Reports Financial Results for the Third Quarter of 2015 3Q15 Total Sales Up 14.4% YoY to $78.8 Million 3Q15 Non-GAAP Net Income Up 23.6% YoY to $26.2 Million 9M15 Total Sales Up 23.2% YoY to $228.2 Million 9M15 Non-GAAP Net Income Up 31.1% YoY to $79.7 Million Raises Forecast for FY15 Non-GAAP Adjusted] []

CBPO [China Biologic Products] 10-Q: (Original Filing)

[] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. David (Xiaoying) Gao Chief Executive Officer] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. Ming Yang Chief Financial Officer (Principal Financial Officer)]

CO [China Cord Blood] SC 13D/A: (Original Filing)

[Convertible note sale agreement Purchaser Golden Meditech Holdings Limited ( Vendor Excellent China Healthcare Investment Limited ( MinterEllison LAWYERS LEVEL 25, ONE PACIFIC PLACE, 88 QUEENSWAY, HONG KONG TEL: +852 2841 6888 FAX: +852 2810 0235 www.minterellison.com Convertible note sale agreement Details 4 Agreed terms 5 1.] []

By | 2016-03-27T08:16:42+00:00 November 3rd, 2015|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] SC 13D/A: Convertible note sale agreement Purchaser Golden Meditech Holdings

[Convertible note sale agreement Purchaser Golden Meditech Holdings Limited ( Vendor Excellent China Healthcare Investment Limited ( MinterEllison LAWYERS LEVEL 25, ONE PACIFIC PLACE, 88 QUEENSWAY, HONG KONG TEL: +852 2841 6888 FAX: +852 2810 0235 www.minterellison.com Convertible note sale agreement Details 4 Agreed terms 5 1.] []

By | 2016-03-27T08:17:41+00:00 November 3rd, 2015|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

KZ [KONGZHONG] 6-K: (Original Filing)

[KongZhong to Announce Third Quarter 2015 Financial Results on November 23rd, 2015 BEIJING, October 27th, 2015 KongZhong Corporation (NASDAQ: KZ), a leading online games publisher and developer in the PRC, announced that it will release its unaudited financial results for the third quarter ended September 30th 2015, after the close of the U.S. market on Monday, November 23rd, 2015. The] []

By | 2016-03-30T18:03:45+00:00 November 3rd, 2015|Categories: Chinese Stocks, KZ, SEC Original|Tags: , , , , , |0 Comments

KZ [KONGZHONG] 6-K: KongZhong to Announce Third Quarter 2015 Financial Results

[KongZhong to Announce Third Quarter 2015 Financial Results on November 23rd, 2015 BEIJING, October 27th, 2015 KongZhong Corporation (NASDAQ: KZ), a leading online games publisher and developer in the PRC, announced that it will release its unaudited financial results for the third quarter ended September 30th 2015, after the close of the U.S. market on Monday, November 23rd, 2015. The] []

By | 2016-03-30T18:04:40+00:00 November 3rd, 2015|Categories: Chinese Stocks, KZ, Webplus ver|Tags: , , , , , |0 Comments

KZ [KONGZHONG] 6-K: (Original Filing)

[KongZhong Special Committee Retains Financial Advisors and Legal Counsel BEIJING, China, November 3, 2015 – KongZhong Corporation (NASDAQ: KZ;) ("KongZhong" or the "Company"), a leading online games publisher and developer in the PRC, today announced that the special committee (the “Special Committee”) of the Company's board of directors has retained Duff & Phelps, LLC and Duff & Phelps Securities LLC] []

By | 2016-03-30T18:06:16+00:00 November 3rd, 2015|Categories: Chinese Stocks, KZ, SEC Original|Tags: , , , , , |0 Comments

KZ [KONGZHONG] 6-K: KongZhong Special Committee Retains Financial Advisors and Legal

[KongZhong Special Committee Retains Financial Advisors and Legal Counsel BEIJING, China, November 3, 2015 – KongZhong Corporation (NASDAQ: KZ;) ("KongZhong" or the "Company"), a leading online games publisher and developer in the PRC, today announced that the special committee (the “Special Committee”) of the Company's board of directors has retained Duff & Phelps, LLC and Duff & Phelps Securities LLC] []

By | 2016-03-30T18:07:26+00:00 November 3rd, 2015|Categories: Chinese Stocks, KZ, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar